Elyse E. Lower
- Physiology top 0.2%
- Sarcoidosis and Beryllium Toxicity Research 119
- Pulmonary and Respiratory Medicine top 0.2%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 91
- Pulmonary Hypertension Research and Treatments 11
- Otorhinolaryngology top 1%
- Ophthalmology top 1%
- Pharmacology top 1%
- Drug-Induced Adverse Reactions 14
-
- HER2/EGFR in Cancer Research 17
-
- Rheumatoid Arthritis Research and Therapies 17
-
- Autoimmune and Inflammatory Disorders 13
-
- Breast Cancer Treatment Studies 11
- Co-authors
- Robert P. BaughmanRoland M. du BoisDeborah BradleyMarjolein DrentRobbin BlauJolanda De VriesAdam H. KaufmanPeter J. Engel
- Journals
- CHEST Journal (21 papers)Breast Cancer Research and Treatment (8 papers)Respiratory Medicine (8 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Elyse E. Lower
157 papers receiving 6.8k citations
Peers
Comparison fields: 5 of 125
- Physiology 4.7k
- Pulmonary and Respiratory Medicine 4.7k
- Otorhinolaryngology 330
- Ophthalmology 471
- Pharmacology 865
Countries citing papers authored by Elyse E. Lower
This map shows the geographic impact of Elyse E. Lower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyse E. Lower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyse E. Lower more than expected).
Fields of papers citing papers by Elyse E. Lower
This network shows the impact of papers produced by Elyse E. Lower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyse E. Lower. The network helps show where Elyse E. Lower may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elyse E. Lower, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 33 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 12 | |
| 10 | 2019 | 17 | |
| 11 | 2018 | 9 | |
| 12 | 2018 | 5 | |
| 13 | 2017 | 27 | |
| 14 | 2017 | 28 | |
| 15 | Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. | 2016 | 33 |
| 16 | 2013 | 87 | |
| 17 | 2012 | 1 | |
| 18 | 2009 | 2 | |
| 19 | 2005 | 89 | |
| 20 | 1996 | 8 |
About Elyse E. Lower
Elyse E. Lower is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Rheumatology, Otorhinolaryngology and Oncology, having authored 164 papers that have together received 7.0k indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (119 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (91 papers), HER2/EGFR in Cancer Research (17 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Drug-Induced Adverse Reactions (14 papers), Autoimmune and Inflammatory Disorders (13 papers), Breast Cancer Treatment Studies (11 papers) and Pulmonary Hypertension Research and Treatments (11 papers). The work is most often cited by research in Physiology (4.7k citations), Pulmonary and Respiratory Medicine (4.7k citations), Otorhinolaryngology (330 citations), Ophthalmology (471 citations) and Pharmacology (865 citations). Elyse E. Lower has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Robert P. Baughman, Roland M. du Bois, Robert P. Baughman, Deborah Bradley, Marjolein Drent, Robbin Blau, Jolanda De Vries, Adam H. Kaufman, Peter J. Engel and Nadera Sweiss. Their work appears in journals such as CHEST Journal, Breast Cancer Research and Treatment, Respiratory Medicine, Seminars in Respiratory and Critical Care Medicine and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.